Biotech

All Articles

' Medical intuition' led FDA advisors to back Zevra's unusual illness med

.Zevra Therapeutics' unusual ailment medication seems to be on the road to approval this loss after ...

Pfizer takes $230M attacked after axing failed DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has blown a $230 thousand h...

AC Immune finds 'site' prospective in Alzheimer's medication data

.After more than twenty years of work with neurodegenerative diseases, Swiss biotech air conditionin...

GSK falls ph. 2 HPV injection over lack of best-in-class prospective

.GSK has actually ditched a phase 2 human papillomavirus (HPV) vaccine coming from its pipeline afte...

OS Therapies refiles $6M IPO to finance HER2 drug, preclinical ADCs

.OS Therapies will definitely detail on the NYSE American stock swap today through a $6.4 thousand I...

ALX's waning CD47 feedback cost sends out supply spiraling down

.ALX Oncology's period 2 gastric cancer cells feedback fee has compromised. After observing its own ...

Ionis axes eye ailment coming from targets of Roche-partnered possibility after data disappoint

.One More of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of assumptio...

Biogen's CEO claimed no dangerous deals in 2023. He's ready to be bold

.While Biogen's pharma peers are seeking for late-stage assets with little threat, chief executive o...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has been actually a biotech seeking a pipe after it junked its own lead possession...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back rights to a very early Alzheimer's ailment course to Denali Rehabs,...